INM — InMed Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for InMed Pharmaceuticals, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	6.22	8.96	6.61	11.1	2.23
Net Total Accounts Receivable
Net Total Receivables	0.088	0.26	0.353	0.465	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.6	11.3	8.69	12.9	2.68
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.904	0.723	1.25	0.992	0.221
Net Intangible Assets
Other Long Term Assets
Total Assets	12.8	14.1	11.8	15.6	3.03
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.32	2	1.97	1.84	1.96
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.71	2.02	2.62	2.15	1.96
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.08	12.1	9.21	13.4	1.08
Total Liabilities & Shareholders' Equity	12.8	14.1	11.8	15.6	3.03
Total Common Shares Outstanding